GlassScriptPhysician profile
Enamul Haque
NPI 1144351693
$7,172.42
in general payments reported to CMS, 2019-2025
8 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,997 · 2021: $82.24 · 2022: $1,236 · 2023: $401 · 2024: $2,913 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,958 · Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,957.90 |
| Food and Beverage | $1,899.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,567.37 | 2022-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Musculoskeletal Transplant Foundation INC. | $1,561.33 | 2022-2025 | |
| Medical Device Business Services, INC. | $1,211.48 | 2019-2022 | |
| Kci USA, INC. | $800.00 | 2019 | |
| Mentor Worldwide LLC | $680.20 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Abbvie INC. | $250.97 | 2023-2025 | |
| Motiva USA, LLC | $57.21 | 2025 | |
| Sientra, INC. | $43.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Enamul Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.